We’re back from SCDM 2018 and observed that attendance appeared highest since its inception. This is a reflection of the voracious appetite that our industry has developed for good, clean data that passes the rigors of regulatory approval. A great deal of interest at...
At a recent partner event, I had the pleasure of speaking with Sally Okun, VP Advocacy, Policy and Patient Safety at PatientsLikeMe®. She shared her thoughts on the increasing role of patients in clinical trials. Her comments were similar to those expressed at a...
